HRAS and cervical carcinoma: HPV-positive human cervical carcinoma-derived cell lines (HeLa) stably transfected with the HRAS gene with its activating mutation progress through the cell cycle faster than control cells by reducing the G1 phase, indicating that HRAS could play an important role in the development of cervical cancer together with the presence of HPV28.